Arax Advisory Partners’s scPharmaceuticals SCPH Stock Holding History

Arax Advisory Partners’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,407	Closed	-$7.98K	–	4473
2025 Q3	$7.98K	Buy	+1,407	New	+$7.21K	﹤0.01%	2690

Arax Advisory Partners's SCPH Position: Q4 2025 in Review

Arax Advisory Partners sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 1,407 shares — an estimated $7.98K sold.

Arax Advisory Partners first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $7.98K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Arax Advisory Partners reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 1,407 scPharmaceuticals shares in Q4 2025, an estimated $7.98K.
Arax Advisory Partners first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's scPharmaceuticals position peaked at $7.98K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.